Company American BriVision (Holding) Corporation OTC Markets
Equities
ABVC
US0247332069
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -84.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 22/06/23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 28/02/21 |
Eugene Jiang
CHM | Chairman | 38 | 30/06/15 |
Chief Tech/Sci/R&D Officer | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 09/07/22 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 30/06/15 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 22/11/17 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 22/11/17 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 22/11/17 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Hsin-Hui Miao
BRD | Director/Board Member | 57 | 03/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,878,376 | 8,003,326 ( 73.57 %) | 26,553 ( 0.2441 %) | 73.57 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |